Synthesis and antifungal activity of pradimicin derivatives. Modifications of the sugar part. 1993

S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
Bristol-Myers Squibb Research Institute, Bristol-Myers Squibb K.K., Tokyo, Japan.

Modifications at the sugar part of pradimicins were carried out by glycosidations of the aglycones or chemical transformations of natural pradimicins and their antifungal activity was evaluated. Among them, some of the D-xylose-modified derivatives (14, 17, 24) showed activity comparable to that of pradimicin A. The structure-activity relationships obtained through there studies clarified the role of the sugar part in the manifestation of antifungal activity: The 5-O-(6-deoxy-beta-D-sugar) is essential for activity and 2'-epi, 3'-oxo and 4'-deoxy sugar derivatives retain activity against yeasts.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009005 Monosaccharides Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. Monosaccharide,Simple Sugar,Simple Sugars,Sugar, Simple,Sugars, Simple
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
September 1993, The Journal of antibiotics,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
September 1992, The Journal of antibiotics,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
March 1993, The Journal of antibiotics,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
October 1990, The Journal of antibiotics,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
February 2022, Bioorganic & medicinal chemistry,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
August 1993, The Journal of antibiotics,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
September 2010, Molecules (Basel, Switzerland),
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
June 2023, Chemistry & biodiversity,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
January 2015, Natural product research,
S Aburaki, and Y Yamashita, and T Ohnuma, and H Kamachi, and T Moriyama, and S Masuyoshi, and H Kamei, and M Konishi, and T Oki
March 1993, The Journal of antibiotics,
Copied contents to your clipboard!